Correlation Between KEYCORP and Bristol Myers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both KEYCORP and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KEYCORP and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between KEYCORP MTN and Bristol Myers Squibb, you can compare the effects of market volatilities on KEYCORP and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KEYCORP with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of KEYCORP and Bristol Myers.

Diversification Opportunities for KEYCORP and Bristol Myers

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between KEYCORP and Bristol is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding KEYCORP MTN and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and KEYCORP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KEYCORP MTN are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of KEYCORP i.e., KEYCORP and Bristol Myers go up and down completely randomly.

Pair Corralation between KEYCORP and Bristol Myers

Assuming the 90 days trading horizon KEYCORP MTN is expected to under-perform the Bristol Myers. In addition to that, KEYCORP is 1.11 times more volatile than Bristol Myers Squibb. It trades about -0.08 of its total potential returns per unit of risk. Bristol Myers Squibb is currently generating about 0.11 per unit of volatility. If you would invest  5,038  in Bristol Myers Squibb on September 24, 2024 and sell it today you would earn a total of  695.00  from holding Bristol Myers Squibb or generate 13.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.46%
ValuesDaily Returns

KEYCORP MTN  vs.  Bristol Myers Squibb

 Performance 
       Timeline  
KEYCORP MTN 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days KEYCORP MTN has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for KEYCORP MTN investors.
Bristol Myers Squibb 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.

KEYCORP and Bristol Myers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with KEYCORP and Bristol Myers

The main advantage of trading using opposite KEYCORP and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KEYCORP position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.
The idea behind KEYCORP MTN and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk